Seeing Is Believing
with an average price target of $-306068.75. This is a potential upside of $-306072.67 (-7807976.28%) from yesterday's end of day stock price of $3.92.
ReShape Lifesciences's activity chart (see below) currently has 21 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 88% with an average time for these price targets to be met of 95.4 days.
Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 17-Jul-2024. First documented stock forecast 31-Oct-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Jul-2024
$290000
1 years 8 months 6 days ago
(17-Jul-2024)
2/2 (100%)
$-107297.22 (-27.01%)
35
$126875
$126859.32 (809051.81%)
$337125
3 years 7 months 6 days ago
(17-Aug-2022)
2/5 (40%)
$58.89 (0.05%)
30
Hold Since 22-May-2019
$326250
$326234.31 (2080576.00%)
$326250
6 years 10 months 1 days ago
(22-May-2019)
2/2 (100%)
$-673750 (-67.38%)
86
Hold Since 26-Feb-2019
$598125
$598109.31 (3814472.75%)
7 years 25 days ago
(26-Feb-2019)
1/1 (100%)
$-401875 (-40.19%)
149
Buy Since 25-Feb-2019
$652500
$652484.31 (4161252.00%)
$543750
7 years 26 days ago
(25-Feb-2019)
2/2 (100%)
$-347500 (-34.75%)
177
What is RSLS (ReShape Lifesciences) average time for price targets to be met?
Which analyst has the current highest performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?
Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?
Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?